(Q34596247)

3 August 2017

Simvastatin-ezetimibe-induced hepatic failure necessitating liver transplantation (English)

1 reference

3 August 2017

liver transplantation

1 reference

8

Andreas G Tzakis

1 reference

3 August 2017

6

Gennaro Selvaggi

1 reference

3 August 2017

1

Sony Tuteja

1 reference

3 August 2017

Nikolaos T Pyrsopoulos

series ordinal

2

object named as

Nikolaos T Pyrsopoulos

1 reference

3 August 2017

4

Kamran Khanmoradi

1 reference

3 August 2017

7

Geoffrey Weisbaum

1 reference

3 August 2017

9

Eugene R Schiff

1 reference

3 August 2017

William R Wolowich

3

1 reference

3 August 2017

David M Levi

series ordinal

5

1 reference

3 August 2017

language of work or name

English

0 references

publication date

1 September 2008

1 reference

3 August 2017

1 reference

3 August 2017

28

1 reference

3 August 2017

9

1 reference

3 August 2017

1188-1193

1 reference

Drug treatment of lipid disorders

3 August 2017

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.28.9.1188

Atorvastatin-induced acute hepatitis with absence of cross-toxicity with simvastatin

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.28.9.1188

Drug-induced lupus-like syndrome associated with severe autoimmune hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.28.9.1188

Fatal liver failure with atorvastatin

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.28.9.1188

Dose-comparison study of the combination of ezetimibe and simvastatin (Vytorin) versus atorvastatin in patients with hypercholesterolemia: the Vytorin Versus Atorvastatin (VYVA) study

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.28.9.1188

Efficacy and safety of ezetimibe co-administered with simvastatin compared with atorvastatin in adults with hypercholesterolemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.28.9.1188

Treatment of high-risk patients with ezetimibe plus simvastatin co-administration versus simvastatin alone to attain National Cholesterol Education Program Adult Treatment Panel III low-density lipoprotein cholesterol goals

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.28.9.1188

Long-term safety and tolerability profile of ezetimibe and atorvastatin coadministration therapy in patients with primary hypercholesterolaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.28.9.1188

Ezetimibe: a review of its metabolism, pharmacokinetics and drug interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.28.9.1188

Comparison of the activity and disposition of the novel cholesterol absorption inhibitor, SCH58235, and its glucuronide, SCH60663

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.28.9.1188

Glucuronidation of statins in animals and humans: a novel mechanism of statin lactonization

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.28.9.1188

Effects of fibrates on metabolism of statins in human hepatocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.28.9.1188

Mechanistic studies on metabolic interactions between gemfibrozil and statins

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.28.9.1188

UDP-glucuronosyltransferases and clinical drug-drug interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.28.9.1188

Pharmacodynamic interaction between the new selective cholesterol absorption inhibitor ezetimibe and simvastatin

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.28.9.1188

Paroxetine associated hepatotoxicity: a report of 3 cases and a review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.28.9.1188

Sertraline hepatotoxicity: a case report and review of the literature on selective serotonin reuptake inhibitor hepatotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.28.9.1188

Hepatotoxicity related to citalopram

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.28.9.1188

Acute liver failure due to enalapril

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.28.9.1188

21 January 2018

Identifiers

DOI

10.1592/PHCO.28.9.1188

1 reference

3 August 2017

1 reference